Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo.
about
Isothermal microcalorimetry to study drugs against Schistosoma mansoniTRP channels in schistosomesNovel therapeutic and prevention approaches for schistosomiasis: reviewInhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and PraziquantelThioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug targetGenetic knockdown and pharmacological inhibition of parasite multidrug resistance transporters disrupts egg production in Schistosoma mansoniPraziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infectionsOrally active antischistosomal early leads identified from the open access malaria boxPraziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trialInhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to PraziquantelThe Schistosoma mansoni Cytochrome P450 (CYP3050A1) Is Essential for Worm Survival and Egg DevelopmentSusceptibility to praziquantel of male and female cercariae of praziquantel-resistant and susceptible isolates of Schistosoma mansoni.Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles.Towards an understanding of the mechanism of action of praziquantel.Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantelActivity of praziquantel enantiomers and main metabolites against Schistosoma mansoni.Schistosomiasis chemotherapy.Schistosome ABC multidrug transporters: From pharmacology to physiology.Diagnostic performance of Schistosoma real-time PCR in urine samples from Kenyan children infected with Schistosoma haematobium: day-to-day variation and follow-up after praziquantel treatment.Pharmacology and potential physiological significance of schistosome multidrug resistance transportersAltered levels of circulating miRNAs are associated Schistosoma japonicum infection in mice.In vitro and in vivo studies of the effect of artemether on Schistosoma mansoniPraziquantel in a clay nanoformulation shows more bioavailability and higher efficacy against murine Schistosoma mansoni infection.Calcium channels of schistosomes: unresolved questions and unexpected answersCa2+ signalling, voltage-gated Ca2+ channels and praziquantel in flatworm neuromusculature.Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance.Efficacy and side effects of praziquantel in the treatment of Schistosomiasis mansoni in schoolchildren in Shesha Kekele Elementary School, Wondo Genet, Southern EthiopiaABC multidrug transporters in schistosomes and other parasitic flatwormsNew approaches for understanding mechanisms of drug resistance in schistosomesUse of cell-free circulating schistosome DNA in serum, urine, semen, and saliva to monitor a case of refractory imported schistosomiasis hematobiaSchistogram changes after administration of antischistosomal drugs in mice at the early phase of Schistosoma mansoni infection.New insight into praziquantel against various developmental stages of schistosomes.Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire.In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium.Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety.Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt.The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases.Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence.Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel.
P2860
Q24605622-CAED7FAA-99F5-4A2C-A4BC-21A7126F3D8AQ26738732-D80FE343-FB0A-450A-A63F-E6BDD314AB3DQ27008897-F027C5FE-2AF4-406C-BBAD-FAC916A83248Q27304398-1E0B07B8-1C15-4DB4-8391-43B7B0EF104EQ28469234-CC29EE4D-8EC3-4D27-80C4-5AF959175955Q28478288-6B1A4149-1826-40F3-8AA7-F57AE41FE45AQ28537753-AA7F65FF-533D-460D-B5F4-5059392CE842Q28538566-AFDAFA3F-4A6F-4CD8-932F-BEA9C79A8C57Q28540831-EDA94B00-5AE1-46B4-BAB2-8FD53F48986EQ28543846-8489624C-8F49-46B5-80E7-F10AFA771026Q28551820-1163039F-8B37-46E6-BC55-1770720B4A42Q33504927-FD73EA2D-1967-4494-870A-AAFCBA4EC594Q33642023-850E4F01-9338-42F6-9C51-F688CC850D11Q33914691-77C57C57-855E-45A1-BC3D-531DC362A1D5Q33960332-4EF41F3D-078A-4E6B-B4C8-FFFF67014E91Q34057535-922B3E9A-B1CD-4052-B526-170A2F26FD91Q34354490-A7A1C1D1-B380-49CE-B0C7-36450A2DFAF6Q34705514-6913CB0D-E380-4F16-87DD-3952179DC122Q35151827-8699EAAF-94BE-4113-8F4A-8D642522EB3BQ35159499-0D031218-CC28-4F27-8BB9-49682D7CDAD7Q35341476-86F72050-1A73-48B5-9BD0-749C1C71A0D1Q35349636-C8B2B3ED-1C99-46F0-9432-84206CE8662FQ35607817-B5C57191-99F3-4684-8388-826870A43EA2Q35752884-9006F3FF-F625-4B17-A2F2-855DAA5E418EQ36434081-7662EBCF-AE6C-4DCE-ADC4-E019ACC6B6ADQ36441487-443858BB-99A6-48F7-BFD0-E9ABCCC400C6Q36719660-BC34919C-0708-4350-B556-0B37A429D903Q37053762-CF5EA2E7-A121-4D21-BEE3-7852DEA3716FQ37177725-7DCA32B4-9763-4FF8-B378-38C1C09DBE3AQ37264263-3A8B250E-E732-46FB-9718-2FBF23B7DB08Q37675186-FE6EDB9B-4E54-447A-9380-1FB04AA902BCQ37943763-88BB42A5-0825-424B-91FB-7E4356C3D252Q38452685-2B0A084D-F44F-4F19-BB9B-9477212F6AA2Q38648427-D94F580B-6338-4244-81AD-B1F1DE18AC8CQ38867800-6A059F83-D800-48CA-A3CE-36906E25EAFEQ38892348-EFCE2D82-8A45-4EA6-B2E4-064586D1F37BQ38943630-70C14940-40B3-4D05-AE0C-66E00457A34FQ39034640-9D984DD4-42A5-4871-B4B8-83D23978A36FQ39164325-3A8359D0-FDBA-4739-B430-12A3B8743EF0Q39544940-E68C330B-DE4E-47C7-B86C-40F597335967
P2860
Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Effects of praziquantel on dif ...... mansoni in vitro and in vivo.
@en
Effects of praziquantel on dif ...... mansoni in vitro and in vivo.
@nl
type
label
Effects of praziquantel on dif ...... mansoni in vitro and in vivo.
@en
Effects of praziquantel on dif ...... mansoni in vitro and in vivo.
@nl
prefLabel
Effects of praziquantel on dif ...... mansoni in vitro and in vivo.
@en
Effects of praziquantel on dif ...... mansoni in vitro and in vivo.
@nl
P2093
P356
P1476
Effects of praziquantel on dif ...... mansoni in vitro and in vivo.
@en
P2093
P304
P356
10.1093/INFDIS/151.6.1130
P407
P577
1985-06-01T00:00:00Z